Notice of AGM

15 May 2026

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Annual Report and Notice of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a world-leading specialist in tissue-healing technologies, is pleased to announce that its Annual Report and Accounts for the year ended 31 December 2025 and Notice of Annual General Meeting ("AGM") have today been sent to shareholders.

The Annual Report and Accounts is available on the Investor Relations section of the Company's website https://admedsol.com/Investor-Relations.

The AGM will be held at 11:00 a.m. at the offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QN on 17 June 2026.

A copy of the proxy form for the AGM and Notice of AGM are available on the Company's website https://admedsol.com/investor-relations/shareholder-information/agm.

- End -

For further information, please visit www.admedsol.com or contact:

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is an innovative tissue healing medical device company delivering high-performing solutions that match or surpass market leaders, clinically, technically, and commercially. From adhesives and sealants, to biosurgical devices and sutures, AMS's products offer superior usability, quality and design. AMS's strength lies in combining advanced material science with applicator device design and development, in collaboration with surgeons and Key Opinion Leaders, creating differentiated devices that improve patient outcomes without compromising quality or affordability.

AMS's scalable, resilient business model is built on disciplined execution, portfolio focus, and capital efficiency. Its diversified product and geographic mix mitigates volatility, ensuring consistent performance even when individual segments fluctuate. Following its acquisition of Peters Surgical, AMS is unlocking operational and commercial synergies, accelerating its US and international expansion, and increasing the percentage of sales made through its direct sales teams. With surgical products driving the lion's share of group revenues and a clear top-line trajectory, AMS is positioned for scalable growth, and long-term value creation.

-